PS2-40: Cystatin C Heralds Early Chronic Kidney Disease Especially in Diabetes (CHECKED): Results from a Pilot Study

BACKGROUND/AIMS: Identifying early chronic kidney disease (CKD) among patients with diabetes impacts the development of diabetic complications, costs, and prevention. Cystatin C may be a better marker for kidney function than serum creatinine (SCr) and estimated glomerular filtration rate (eGFR), ho...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vupputuri, Suma, Robinson, Brandi, Brannon, Elissa, Owen-Smith, Ashli
Médium: Artigo
Jazyk:Inglês
Vydáno: Marshfield Clinic 2011
Témata:
SELECTED ABSTRACTS - HMORN 2011: Diabetes, Obesity, and Physical Activity
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251441/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.ps2-40
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky